نتایج جستجو برای: ulcerative colitis uc

تعداد نتایج: 39878  

Journal: :middle east journal of digestive diseases 0
mojgan mohammadi department of immunology, school of medicine, mashhad university of medical sciences, mashhad, iran mohammad javad zahedi department of gastroenterology, afzalipour hospital, kerman university of medical sciences, kerman, iran amin reza nikpoor department of immunology, school of medicine, mashhad university of medical sciences, mashhad, iran mehdi nazem pharmaceutics department, kerman university of medical sciences, kerman, iran payam khazaeli pharmaceutics department, kerman university of medical sciences, kerman, iran mohammad mahdi hayatbakhsh gastroenterology and hepatology research center, institute of basic and clinical physiology sciences, kerman university of medical sciences, kerman, iran

background: ulcerative colitis (uc) is a multi-factorial autoimmune disease. p-glycoprotein is encoded by the multidrug resistance 1 (mdr1) gene. the c3435t polymorphism in the mdr1 gene is correlated with low p-glycoprotein expression. additionally, vitamin d has regulatory effects on the immune system. the aim of our study was to determine the association between the c3435t mdr1 polymorphism ...

Journal: :Digestive diseases 2009
Gerhard Rogler

Ulcerative colitis (UC) is a chronic and relapsing inflammation limited to the colonic mucosa and always involving the rectum with variable extension towards the cecum. The aim of medical treatment is to induce and maintain clinical remission. In contrast to Crohn's disease for which a 'top-down' or 'early aggressive' therapy is discussed, in UC the concept of a step-up treatment is still valid...

Journal: :Digestion 2012
Marc Girardin Michael Manz Christine Manser Luc Biedermann Roger Wanner Pascal Frei Ekaterina Safroneeva Christian Mottet Gerhard Rogler Alain M Schoepfer

BACKGROUND AND AIMS Medical therapy of inflammatory bowel disease (IBD) is becoming more complex, given the increasing choice of drugs to treat Crohn's disease (CD) and ulcerative colitis (UC). We aimed to summarize the current guidelines for first-line treatments in IBD. METHODS An extensive literature search with focus on the guidelines of the European Crohn's and Colitis Organisation for t...

2011
Shigeki Bamba Tomoyuki Tsujikawa Masaya Sasaki Yoshihide Fujiyama Akira Andoh

Ulcerative colitis (UC) is characterized by a long-standing chronic course with remissions and exacerbations. Previously, patients do not respond to 5-aminosalicylic acid compounds and corticosteroids are considered for colectomies, however, in recent years, alternative treatments emerged for steroid-refractory or steroid-dependent UC. In this review article, we focus on immunomodulators (such ...

Journal: :Journal of pharmacological sciences 2004
Ryotaro Kojima Satoko Kuroda Tomiko Ohkishi Koichi Nakamaru Shigeki Hatakeyama

A number of experimental models of colitis have been proposed. However, few studies have presented T helper-2 (Th-2) type colitis models that substitute for human ulcerative colitis (UC). In recent years, the murine oxazolone (OXA)-induced colitis model came to be accepted as a Th-2 type model, but it has yet to be used in any pharmacological study. In the present study, we modified the OXA-ind...

2015
Naveen Raj Matthew Arkebauer Barry Waters Brucha Dickinson

Ulcerative colitis (UC) is a chronic, debilitating condition characterized by inflammation of the colonic mucosa. It is regarded as a systemic inflammatory disorder that can affect a number of organ systems. Central nervous system disease associated with UC is a rare sequela of inflammatory bowel disease, occurring in less than 5% of cases. These manifestations include arterial and venous throm...

2011
Eva D. Papadimitraki Mubarak Ahamed Nicholas H. Bunce

Ulcerative colitis (UC) is a chronic inflammatory disease that predominantly affects the gastrointestinal (GI) tract but can involve extraintestinal organs including musculoskeletal system and skin. The most frequent cardiac manifestations of UC are pericarditis and myocarditis. Patients display an increased risk for venous thromboembolic complications and mesenteric ischemia, but the associati...

2016
Ru Chen Lisa A Lai Teresa A Brentnall Sheng Pan

Patients with extensive ulcerative colitis (UC) of more than eight years duration have an increased risk of colorectal cancer. Molecular biomarkers for dysplasia and cancer could have a great clinical value in managing cancer risk in these UC patients. Using a wide range of molecular techniques - including cutting-edge OMICS technologies - recent studies have identified clinically relevant biom...

2009
Ying-De Wang Xiao-Yan Tan Ke Zhang

BACKGROUND Both plasma and mucosal levels of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) have been shown to be independently correlated with ulcerative colitis (UC), but their relationship with each other and to disease severity remains unclear. This study aims to evaluate the relationship between colonic mucosal and plasma levels of MMP-1 and TIMP-1 ...

Journal: :Gastroenterology research and practice 2016
Ping Yao Min Cui Haikun Wang Hongliang Gao Lei Wang Tao Yang Yongbo Cheng

Aim. To study the correlation between intestinal flora and ulcerative colitis by analyzing the abundance of Bacteroides, Fusobacterium, Clostridium, Bifidobacterium spp., and Faecalibacterium prausnitzii in the intestinal of ulcerative colitis (UC) patients and healthy controls with Uygur and Han ethnic. Methods. Bacterial genomic DNA was extracted from fecal samples and analyzed with real-time...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید